Nobel Prize Laureate Dr Randy Schekman Joins Coastar’s Scientific Advisory Board
Press Release Coastar Therapeutics Welcomes Nobel Prize Winner Randy Schekman to Scientific Advisory Board San Diego, March 6, 2025 – Coastar Therapeutics Inc., a biotechnology company developing novel delivery technologies to supercharge cell and gene therapies, proudly announces that Nobel Prize Laureate Dr. Randy Schekman has joined its Scientific Advisory Board. A globally recognized leader […]
Coastar Therapeutics Nominated for Best Startup of Prix Galien USA Award
Coastar Therapeutics Nominated for Best Startup of Prix Galien USA Award New York and San Diego, November 5, 2024 – Coastar Therapeutics Inc., a biotechnology company developing novel delivery technologies to supercharge cell and gene therapies, announced that it has been nominated for Best Startup of the 2024 Prix Galien USA Award. The Prix Galien […]
Coastar Therapeutics Joins Johnson & Johnson’s JLABS
Coastar Therapeutics Joins Johnson & Johnson’s JLABS SAN DIEGO, October 1, 2024 – Coastar Therapeutics Inc., a biotechnology company developing novel delivery technologies to supercharge cell and gene therapies, announced that it has joined JLABS, an early stage biotech accelerator program of Johnson & Johnson Innovation. “We are excited to be part of JLABS, where […]
Coastar Therapeutics and SOHM to Collaborate to Revolutionize Genome Editing
Press Release Coastar Therapeutics Announces Collaboration with SOHM, Inc. to Advance Gene Editing Technologies San Diego, April 2, 2024 – Coastar Therapeutics, a pioneering biotechnology company specializing in innovative drug and biological delivery systems, is pleased to announce a strategic collaboration with SOHM, Inc. (OTC PINK: SHMN), a biopharmaceutical company focused on gene editing technologies. […]
Coastar Therapeutics to Participate in JP Morgan Conference Events
Coastar Therapeutics to Present in JP Morgan Conference Events SAN DIEGO, January 5, 2023 – Coastar Therapeutics Inc., a biotechnology company developing novel delivery technologies to supercharge cell and gene therapies, announced that it will be presenting at events of the 42nd JP Morgan Healthcare Conference, January 8-11 in San Francisco. Coastar’s innovative cell membrane […]
Coastar Therapeutics to Present at BIO Future and BIO Investor Conferences
Coastar Therapeutics to Present at BioFuture and BIO Investor Conferences SAN DIEGO, Sep 7, 2023 – Coastar Therapeutics Inc., a biotech company developing a delivery technology for cancer immunotherapy and gene therapy, announced that it will be presenting at two biotech conferences – the BioFuture on October 4-5, 2023 in New York and the BIO […]